Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (vol 392, pg 31, 2018)

被引：0
|
作者：
Jaber, S.
Paugam, C.
Futier, E.
机构：
来源：
LANCET | 2018年 / 392卷 / 10163期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2440 / 2440
页数：1
相关论文
共 50 条
  • [11] Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial
    Crombie, Nicholas
    Doughty, Heidi A.
    Bishop, Jonathan R. B.
    Desai, Amisha
    Dixon, Emily F.
    Hancox, James M.
    Herbert, Mike J.
    Leech, Caroline
    Lewis, Simon J.
    Nash, Mark R.
    Naumann, David N.
    Slinn, Gemma
    Smith, Hazel
    Smith, Iain M.
    Wale, Rebekah K.
    Wilson, Alastair
    Ives, Natalie
    Perkins, Gavin D.
    LANCET HAEMATOLOGY, 2022, 9 (04): : E250 - E261
  • [12] Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
    Chen, Yu-Pei
    Liu, Xu
    Zhou, Qin
    Yang, Kun-Yu
    Jin, Feng
    Zhu, Xiao-Dong
    Shi, Mei
    Hu, Guo-Qing
    Hu, Wei-Han
    Sun, Yan
    Wu, Hong-Fen
    Wu, Hui
    Lin, Qin
    Wang, Hui
    Tian, Ye
    Zhang, Ning
    Wang, Xi-Cheng
    Shen, Liang-Fang
    Liu, Zheng-Zheng
    Huang, Jing
    Luo, Xiu-Ling
    Li, Ling
    Zang, Jian
    Mei, Qi
    Zheng, Bao-Min
    Yue, Dan
    Xu, Jing
    Wu, San-Gang
    Shi, Yan-Xia
    Mao, Yan-Ping
    Chen, Lei
    Li, Wen-Fei
    Zhou, Guan-Qun
    Sun, Rui
    Guo, Rui
    Zhang, Yuan
    Xu, Cheng
    Lv, Jia-Wei
    Guo, Ying
    Feng, Hui-Xia
    Tang, Ling-Long
    Xie, Fang-Yun
    Sun, Ying
    Ma, Jun
    LANCET, 2021, 398 (10297): : 303 - 313
  • [13] Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial (vol 16, pg 1473, 2015)
    Motzer, R. J.
    Hutson, T. E.
    Glen, H.
    LANCET ONCOLOGY, 2018, 19 (10): : E509 - E509
  • [14] Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial (vol 16, pg 1479, 2015)
    Motzer, R. J.
    Hutson, T. E.
    Glen, H.
    LANCET ONCOLOGY, 2016, 17 (07): : E270 - E270
  • [15] Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial (vol 7, pg 294, 2022)
    Danese, S.
    Vermeire, S.
    D'Haens, G.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : E8 - E8
  • [16] Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)
    Dhar, Raja.
    Kirkpatrick, John K.
    Gilbert, Laura
    Khanna, Arjun
    Modi, Mahavir Madhavdas
    Chawla, Rakesh T.
    Dalal, Sonia
    Maturu, Venkata Nagarjuna D.
    Stern, Marcel
    Keppler, Oliver T.
    Djukanovic, Ratko
    Gadola, Stephan D.
    PLOS ONE, 2023, 18 (01):
  • [17] Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting (vol 389, pg 1528, 2017)
    Breitenstein, C.
    Grewe, T.
    Floeel, A.
    LANCET, 2017, 389 (10078): : 1518 - 1518
  • [18] Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial (vol 389, pg 255, 2016)
    Rittmeyer, A.
    Barlesi, F.
    Waterkamp, D.
    LANCET, 2017, 389 (10077): : E5 - E5
  • [19] Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial (vol 389, pg 255, 2017)
    Rittmeyer, A.
    Barlesi, F.
    Waterkamp, D.
    LANCET, 2017, 389 (10068): : E2 - E2
  • [20] Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial
    Del Mastro, Lucia
    Mansutti, Mauro
    Bisagni, Giancarlo
    Ponzone, Riccardo
    Durando, Antonio
    Amaducci, Laura
    Campadelli, Enrico
    Cognetti, Francesco
    Frassoldati, Antonio
    Michelotti, Andrea
    Mura, Silvia
    Urracci, Ylenia
    Sanna, Giovanni
    Gori, Stefania
    De Placido, Sabino
    Garrone, Ornella
    Fabi, Alessandra
    Barone, Carla
    Tamberi, Stefano
    Bighin, Claudia
    Puglisi, Fabio
    Moretti, Gabriella
    Arpino, Grazia
    Ballestrero, Alberto
    Poggio, Francesca
    Lambertini, Matteo
    Montemurro, Filippo
    Bruzzi, Paolo
    LANCET ONCOLOGY, 2021, 22 (10): : 1458 - 1467
12345